Sign in
8-K

Current Report

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-228289

Executive or director change · Bylaws or fiscal year change

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading fdmt-20250930.htm…